EFG Asset Management Americas Corp. Lowers Stake in UnitedHealth Group Incorporated (NYSE:UNH)

EFG Asset Management Americas Corp. decreased its position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 1.2% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 28,829 shares of the healthcare conglomerate’s stock after selling 338 shares during the quarter. UnitedHealth Group makes up 3.5% of EFG Asset Management Americas Corp.’s portfolio, making the stock its 4th biggest holding. EFG Asset Management Americas Corp.’s holdings in UnitedHealth Group were worth $14,845,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of UNH. Advocacy Wealth Management Services LLC increased its position in UnitedHealth Group by 75.8% in the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 25 shares in the last quarter. Cascade Investment Advisors Inc. increased its position in UnitedHealth Group by 100.0% in the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 30 shares in the last quarter. Rise Advisors LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $38,000. Evolution Advisers Inc. purchased a new stake in shares of UnitedHealth Group during the first quarter worth about $38,000. Finally, Cordant Inc. purchased a new stake in shares of UnitedHealth Group during the first quarter worth about $45,000. Hedge funds and other institutional investors own 87.25% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Andrew Witty sold 11,376 shares of UnitedHealth Group stock in a transaction on Monday, July 18th. The stock was sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the completion of the sale, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other UnitedHealth Group news, CEO Andrew Witty sold 11,376 shares of UnitedHealth Group stock in a transaction on Monday, July 18th. The stock was sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the completion of the sale, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Stephen J. Hemsley sold 99,312 shares of UnitedHealth Group stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total value of $53,059,422.24. Following the completion of the transaction, the director now owns 787,372 shares in the company, valued at $420,669,238.44. The disclosure for this sale can be found here. Insiders sold a total of 139,051 shares of company stock valued at $74,450,958 in the last ninety days. Corporate insiders own 0.40% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $517.46 on Friday. UnitedHealth Group Incorporated has a 52-week low of $383.12 and a 52-week high of $553.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.77 and a current ratio of 0.77. The firm has a market capitalization of $484.02 billion, a P/E ratio of 27.02, a P/E/G ratio of 1.61 and a beta of 0.76. The stock has a 50 day moving average price of $530.11 and a 200 day moving average price of $512.45.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The firm had revenue of $80.33 billion during the quarter, compared to analyst estimates of $79.68 billion. During the same period last year, the company earned $4.70 EPS. UnitedHealth Group’s quarterly revenue was up 12.6% compared to the same quarter last year. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th were given a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a yield of 1.28%. The ex-dividend date was Friday, September 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.46%.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on UNH. UBS Group increased their target price on UnitedHealth Group from $545.00 to $570.00 and gave the stock a “neutral” rating in a research report on Thursday, July 21st. Argus raised their price target on UnitedHealth Group from $580.00 to $650.00 and gave the company a “buy” rating in a report on Monday, July 25th. Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $556.00 to $569.00 and gave the company a “buy” rating in a report on Thursday, September 8th. Oppenheimer raised their price target on UnitedHealth Group from $600.00 to $610.00 and gave the company an “outperform” rating in a report on Monday, July 18th. Finally, Loop Capital started coverage on UnitedHealth Group in a report on Thursday, June 16th. They set a “buy” rating and a $575.00 price target for the company. Three analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $586.40.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.